SHSE:603983 (China)
Â
Class A
Â¥
34.53
(+0.67%)
Dec 26
Business Description
Guangdong Marubi Biotechnology Co Ltd
ISIN : CNE100003M51
Share Class Description:
SHSE:603983: Class ACompare
Compare
Traded in other countries / regions
603983.China IPO Date
2019-07-25Description
Guangdong Marubi Biotechnology Co Ltd is engaged in the research and development, design, production, sales and service of various types of cosmetics.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.31 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | 0.61 | |||||
| Interest Coverage | 65.71 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 10.14 | |||||
| Beneish M-Score | -2.44 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.6 | |||||
| 3-Year EBITDA Growth Rate | -15.7 | |||||
| 3-Year EPS without NRI Growth Rate | -22.5 | |||||
| 3-Year Book Growth Rate | 4 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 43.01 | |||||
| Future 3-5Y Total Revenue Growth Rate | 25.49 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 61.26 | |||||
| 9-Day RSI | 62.01 | |||||
| 14-Day RSI | 61.49 | |||||
| 6-1 Month Momentum % | -4.92 | |||||
| 12-1 Month Momentum % | 14.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.68 | |||||
| Quick Ratio | 2.48 | |||||
| Cash Ratio | 1.91 | |||||
| Days Inventory | 92.07 | |||||
| Days Sales Outstanding | 6.71 | |||||
| Days Payable | 140.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.24 | |||||
| Dividend Payout Ratio | 0.75 | |||||
| 3-Year Dividend Growth Rate | -13.8 | |||||
| Forward Dividend Yield % | 2.24 | |||||
| 5-Year Yield-on-Cost % | 2.22 | |||||
| Shareholder Yield % | 2.95 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 73.52 | |||||
| Operating Margin % | 11.08 | |||||
| Net Margin % | 12.28 | |||||
| FCF Margin % | 1.14 | |||||
| ROE % | 9.68 | |||||
| ROA % | 7.5 | |||||
| ROIC % | 10.27 | |||||
| ROC (Joel Greenblatt) % | 46.33 | |||||
| ROCE % | 11.99 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 42.11 | |||||
| Forward PE Ratio | 30.28 | |||||
| PE Ratio without NRI | 49.9 | |||||
| Shiller PE Ratio | 38.37 | |||||
| Price-to-Owner-Earnings | 295.06 | |||||
| PS Ratio | 5.2 | |||||
| PB Ratio | 4.1 | |||||
| Price-to-Tangible-Book | 5.18 | |||||
| Price-to-Free-Cash-Flow | 367.31 | |||||
| Price-to-Operating-Cash-Flow | 39.63 | |||||
| EV-to-EBIT | 29.6 | |||||
| EV-to-Forward-EBIT | 24.46 | |||||
| EV-to-EBITDA | 29.6 | |||||
| EV-to-Forward-EBITDA | 21.19 | |||||
| EV-to-Revenue | 4.63 | |||||
| EV-to-Forward-Revenue | 3.22 | |||||
| EV-to-FCF | 404.56 | |||||
| Price-to-Projected-FCF | 4.63 | |||||
| Price-to-Graham-Number | 3.39 | |||||
| Price-to-Net-Current-Asset-Value | 8.99 | |||||
| Price-to-Net-Cash | 17.44 | |||||
| Earnings Yield (Greenblatt) % | 3.38 | |||||
| FCF Yield % | 0.22 | |||||
| Forward Rate of Return (Yacktman) % | -16.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Guangdong Marubi Biotechnology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,641.488 | ||
| EPS (TTM) (Â¥) | 0.82 | ||
| Beta | 1.44 | ||
| Volatility % | 42.78 | ||
| 14-Day RSI | 61.49 | ||
| 14-Day ATR (Â¥) | 1.586605 | ||
| 20-Day SMA (Â¥) | 32.0995 | ||
| 12-1 Month Momentum % | 14.22 | ||
| 52-Week Range (Â¥) | 20.17 - 36.82 | ||
| Shares Outstanding (Mil) | 401 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Guangdong Marubi Biotechnology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Guangdong Marubi Biotechnology Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Guangdong Marubi Biotechnology Co Ltd Frequently Asked Questions
What is Guangdong Marubi Biotechnology Co Ltd(SHSE:603983)'s stock price today?
The current price of SHSE:603983 is ¥34.53. The 52 week high of SHSE:603983 is ¥36.82 and 52 week low is ¥20.17.
When is next earnings date of Guangdong Marubi Biotechnology Co Ltd(SHSE:603983)?
The next earnings date of Guangdong Marubi Biotechnology Co Ltd(SHSE:603983) is .
Does Guangdong Marubi Biotechnology Co Ltd(SHSE:603983) pay dividends? If so, how much?
The Dividend Yield %  of Guangdong Marubi Biotechnology Co Ltd(SHSE:603983) is 2.24% (As of Today), Highest Dividend Payout Ratio of Guangdong Marubi Biotechnology Co Ltd(SHSE:603983) was 0.78. The lowest was 0.39. And the median was 0.55. The  Forward Dividend Yield % of Guangdong Marubi Biotechnology Co Ltd(SHSE:603983) is 2.24%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers